These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 26482227

  • 1. Tumor size, stage and grade alterations of urinary peptidome in RCC.
    Chinello C, Cazzaniga M, De Sio G, Smith AJ, Grasso A, Rocco B, Signorini S, Grasso M, Bosari S, Zoppis I, Mauri G, Magni F.
    J Transl Med; 2015 Oct 20; 13():332. PubMed ID: 26482227
    [Abstract] [Full Text] [Related]

  • 2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.
    Urol Oncol; 2016 Jan 20; 34(1):5.e11-25. PubMed ID: 26420021
    [Abstract] [Full Text] [Related]

  • 3. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 4. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
    Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro SS, Ferrero S, Nicolardi S, van der Burgt YE, Deelder AM, Magni F.
    J Proteomics; 2012 Dec 05; 76 Spec No.():125-40. PubMed ID: 22868251
    [Abstract] [Full Text] [Related]

  • 5. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM.
    Int J Cancer; 2020 Apr 15; 146(8):2315-2325. PubMed ID: 31465112
    [Abstract] [Full Text] [Related]

  • 6. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.
    Wu DL, Zhang WH, Wang WJ, Jing SB, Xu YM.
    Technol Cancer Res Treat; 2008 Jun 15; 7(3):155-60. PubMed ID: 18473487
    [Abstract] [Full Text] [Related]

  • 7. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G, Pereira DA, Sandim V, Ornellas AA, Escher N, Melle C, von Eggeling F.
    Int Braz J Urol; 2013 Jun 15; 39(2):228-39. PubMed ID: 23683669
    [Abstract] [Full Text] [Related]

  • 8. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
    Papale M, Vocino G, Lucarelli G, Rutigliano M, Gigante M, Rocchetti MT, Pesce F, Sanguedolce F, Bufo P, Battaglia M, Stallone G, Grandaliano G, Carrieri G, Gesualdo L, Ranieri E.
    Oncotarget; 2017 Jun 20; 8(25):40412-40424. PubMed ID: 28418894
    [Abstract] [Full Text] [Related]

  • 9. Prognostic urinary miRNAs for the assessment of small renal masses.
    Di Meo A, Brown MD, Finelli A, Jewett MAS, Diamandis EP, Yousef GM.
    Clin Biochem; 2020 Jan 20; 75():15-22. PubMed ID: 31672647
    [Abstract] [Full Text] [Related]

  • 10. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M, Moreira N, Pinto J, Pires-Luís AS, Henrique R, Jerónimo C, Bastos ML, Gil AM, Carvalho M, Guedes de Pinho P.
    J Cell Mol Med; 2017 Sep 20; 21(9):2092-2105. PubMed ID: 28378454
    [Abstract] [Full Text] [Related]

  • 11. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
    Yang J, Yang J, Gao Y, Zhao L, Liu L, Qin Y, Wang X, Song T, Huang C.
    PLoS One; 2014 Sep 20; 9(11):e111364. PubMed ID: 25368985
    [Abstract] [Full Text] [Related]

  • 12. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
    Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MAS, Diamandis EP, Yousef GM.
    Am J Pathol; 2019 Dec 20; 189(12):2366-2376. PubMed ID: 31761032
    [Abstract] [Full Text] [Related]

  • 13. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.
    Rogers MA, Clarke P, Noble J, Munro NP, Paul A, Selby PJ, Banks RE.
    Cancer Res; 2003 Oct 15; 63(20):6971-83. PubMed ID: 14583499
    [Abstract] [Full Text] [Related]

  • 14. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
    Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS.
    J Proteomics; 2014 Feb 26; 98():44-58. PubMed ID: 24374379
    [Abstract] [Full Text] [Related]

  • 15. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
    Kaya K, Ayan S, Gokce G, Kilicarslan H, Yildiz E, Gultekin EY.
    Scand J Urol Nephrol; 2005 Feb 26; 39(1):25-9. PubMed ID: 15764267
    [Abstract] [Full Text] [Related]

  • 16. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
    Sato T, Kawasaki Y, Maekawa M, Takasaki S, Shimada S, Morozumi K, Sato M, Kawamorita N, Yamashita S, Mitsuzuka K, Mano N, Ito A.
    Cancer Sci; 2020 Jul 26; 111(7):2570-2578. PubMed ID: 32350988
    [Abstract] [Full Text] [Related]

  • 17. Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.
    Chinello C, Cazzaniga M, De Sio G, Smith AJ, Gianazza E, Grasso A, Rocco F, Signorini S, Grasso M, Bosari S, Zoppis I, Dakna M, van der Burgt YE, Mauri G, Magni F.
    PLoS One; 2014 Jul 26; 9(9):e106684. PubMed ID: 25202906
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Protein Profiling in a Cohort of Egyptian Population with Renal Cell Carcinoma and Benign Kidney Neoplasms.
    Kandil NS, Ghazala RA, El Sharkawy RM, Youssif TA, Noha Abouseda N.
    Asian Pac J Cancer Prev; 2019 Jul 01; 20(7):2145-2152. PubMed ID: 31350978
    [Abstract] [Full Text] [Related]

  • 19. Preliminary Application of WCX Magnetic Bead-Based Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Analyzing the Urine of Renal Clear Cell Carcinoma.
    Dong DX, Ji ZG, Li HZ, Yan WG, Zhang YS.
    Chin Med Sci J; 2017 Dec 30; 32(4):248-252. PubMed ID: 29301600
    [Abstract] [Full Text] [Related]

  • 20. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF.
    Cancer Lett; 2009 Sep 18; 282(2):205-13. PubMed ID: 19362769
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.